ATE82860T1 - Thrombolytisches agens. - Google Patents
Thrombolytisches agens.Info
- Publication number
- ATE82860T1 ATE82860T1 AT88114903T AT88114903T ATE82860T1 AT E82860 T1 ATE82860 T1 AT E82860T1 AT 88114903 T AT88114903 T AT 88114903T AT 88114903 T AT88114903 T AT 88114903T AT E82860 T1 ATE82860 T1 AT E82860T1
- Authority
- AT
- Austria
- Prior art keywords
- thrombolytic agent
- urokinase
- plasminogen
- lys
- pro
- Prior art date
Links
- 239000003527 fibrinolytic agent Substances 0.000 title 1
- 229960000103 thrombolytic agent Drugs 0.000 title 1
- 108010087750 lysyl-plasminogen Proteins 0.000 abstract 2
- 108010073863 saruplase Proteins 0.000 abstract 2
- 238000001802 infusion Methods 0.000 abstract 1
- 238000002347 injection Methods 0.000 abstract 1
- 239000007924 injection Substances 0.000 abstract 1
- 230000002537 thrombolytic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/49—Urokinase; Tissue plasminogen activator
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Biomedical Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB878721951A GB8721951D0 (en) | 1987-09-18 | 1987-09-18 | Organic compounds |
| EP88114903A EP0307847B1 (en) | 1987-09-18 | 1988-09-13 | Thrombolytic agent |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE82860T1 true ATE82860T1 (de) | 1992-12-15 |
Family
ID=10623981
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT88114903T ATE82860T1 (de) | 1987-09-18 | 1988-09-13 | Thrombolytisches agens. |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP0307847B1 (OSRAM) |
| JP (1) | JP2820699B2 (OSRAM) |
| AT (1) | ATE82860T1 (OSRAM) |
| AU (1) | AU623347B2 (OSRAM) |
| CA (1) | CA1337046C (OSRAM) |
| DE (1) | DE3876348T2 (OSRAM) |
| DK (1) | DK518788A (OSRAM) |
| ES (1) | ES2053658T3 (OSRAM) |
| GB (1) | GB8721951D0 (OSRAM) |
| GR (1) | GR3007194T3 (OSRAM) |
| NZ (1) | NZ226217A (OSRAM) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2764264B2 (ja) * | 1987-10-01 | 1998-06-11 | 株式会社ミドリ十字 | 線溶活性増強剤 |
| AT402367B (de) * | 1990-10-11 | 1997-04-25 | Immuno Ag | Pharmazeutische zubereitung auf basis von lys-plasminogen |
| AT402263B (de) * | 1991-06-20 | 1997-03-25 | Immuno Ag | Pharmazeutische präparation enthaltend eine thrombolytisch wirkende substanz |
| WO1994001128A1 (en) * | 1992-07-01 | 1994-01-20 | Beth Israel Hospital Boston | Enhancement of thrombolytic therapy with deglycosylated plasminogen |
| DE4320294A1 (de) * | 1993-06-18 | 1994-12-22 | Immuno Ag | Verwendung von humanem Protein C zur Verhinderung und Behandlung von Thrombozytenablagerungen |
| DE4411143C2 (de) * | 1994-03-30 | 1996-08-01 | Immuno Ag | Thrombosemittel |
| US7202066B2 (en) | 2002-01-29 | 2007-04-10 | Carrington Laboratories, Inc. | Combination of a growth factor and a protease enzyme |
| DK3391902T5 (da) * | 2015-12-18 | 2024-09-23 | Talengen Int Ltd | Plasminogen til anvendelse i behandlingen af diabetisk angiokardiopati |
| CN106890318A (zh) * | 2015-12-18 | 2017-06-27 | 深圳瑞健生命科学研究院有限公司 | 一种预防和治疗糖尿病性心脏病的新方法 |
| JP7213553B2 (ja) | 2016-12-15 | 2023-01-27 | タレンゲン インターナショナル リミテッド | 肺の繊維化を予防及び治療するための方法 |
| JP7175270B2 (ja) | 2016-12-15 | 2022-11-18 | タレンゲン インターナショナル リミテッド | グルカゴン、インスリンを正常なバランスに戻らせる方法 |
| US11207387B2 (en) | 2016-12-15 | 2021-12-28 | Talengen International Limited | Method and drug for preventing and treating obesity |
| TW202123963A (zh) | 2016-12-15 | 2021-07-01 | 大陸商深圳瑞健生命科學研究院有限公司 | 一種治療冠狀動脈粥樣硬化及其併發症的方法 |
| WO2018107707A1 (zh) * | 2016-12-15 | 2018-06-21 | 深圳瑞健生命科学研究院有限公司 | 一种改善心脏病变的方法 |
| JP7335609B2 (ja) | 2017-06-19 | 2023-08-30 | タレンゲン インターナショナル リミテッド | Ｇｌｐ－１／ｇｌｐ－１ｒを調節制御する方法および薬剤 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2504921A1 (fr) * | 1981-04-30 | 1982-11-05 | Choay Sa | Medicament nouveau constitue par un complexe aprotinine-plasmine et procede de preparation de ce nouveau complexe |
| IL80166A0 (en) * | 1985-10-01 | 1986-12-31 | American Home Prod | Method of enhancing t-pa and scu-pa production |
-
1987
- 1987-09-18 GB GB878721951A patent/GB8721951D0/en active Pending
-
1988
- 1988-09-13 ES ES88114903T patent/ES2053658T3/es not_active Expired - Lifetime
- 1988-09-13 AT AT88114903T patent/ATE82860T1/de not_active IP Right Cessation
- 1988-09-13 DE DE8888114903T patent/DE3876348T2/de not_active Expired - Fee Related
- 1988-09-13 EP EP88114903A patent/EP0307847B1/en not_active Expired - Lifetime
- 1988-09-16 JP JP63233362A patent/JP2820699B2/ja not_active Expired - Fee Related
- 1988-09-16 DK DK518788A patent/DK518788A/da not_active Application Discontinuation
- 1988-09-16 CA CA000577696A patent/CA1337046C/en not_active Expired - Fee Related
- 1988-09-16 NZ NZ226217A patent/NZ226217A/en unknown
- 1988-09-19 AU AU22400/88A patent/AU623347B2/en not_active Ceased
-
1993
- 1993-03-02 GR GR930400439T patent/GR3007194T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE3876348T2 (de) | 1993-06-09 |
| GB8721951D0 (en) | 1987-10-28 |
| DK518788D0 (da) | 1988-09-16 |
| NZ226217A (en) | 1991-07-26 |
| EP0307847A3 (en) | 1990-03-07 |
| JP2820699B2 (ja) | 1998-11-05 |
| DE3876348D1 (en) | 1993-01-14 |
| EP0307847B1 (en) | 1992-12-02 |
| DK518788A (da) | 1989-03-19 |
| AU2240088A (en) | 1989-03-23 |
| JPH0283335A (ja) | 1990-03-23 |
| AU623347B2 (en) | 1992-05-14 |
| GR3007194T3 (OSRAM) | 1993-07-30 |
| EP0307847A2 (en) | 1989-03-22 |
| ES2053658T3 (es) | 1994-08-01 |
| CA1337046C (en) | 1995-09-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE82860T1 (de) | Thrombolytisches agens. | |
| ATE79252T1 (de) | Zusammensetzung mit einem biologisch abbaubaren augenimplantat. | |
| FI894361A7 (fi) | Injektori lääkerakeiden ihonalaiseksi annostelemiseksi | |
| DK582188A (da) | Stabile interferonkomplekser | |
| DK463989A (da) | Farmaceutisk virksom kombination | |
| BG47033A3 (en) | Method for preparing of derivatives of imidazolamine | |
| ATE72991T1 (de) | Nasale verabreichung von arzneimitteln. | |
| OA08940A (en) | Single-use, self-annulling injection syringe. | |
| NO172344C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte flavonoidforbindelser og salter | |
| MX9203554A (es) | Un dispositivo osmotico para administrar doxazosin | |
| NO880182L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive 1,2-dihydro-3h-indazol-3-on-derivater. | |
| NO883122D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive arylamid-derivater. | |
| NO864130L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive karboksamid-derivater. | |
| DE69032000D1 (de) | Behandlung kardialer Dysfunktion mit 15-Ketoprostaglandinderivaten | |
| NO306537B1 (no) | Anvendelse av en inhibitor for fremstilling av et medikament | |
| ES2019634B3 (es) | Terapia con clorfeniramina. | |
| NO881768D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive 1,3-dioksaner. | |
| NO881884L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive pyrrolidin-derivater. | |
| DE3876425D1 (de) | Gesteuerte verabreichung eines heilmittels an blut. | |
| NO882282D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive pyrazin-amider. | |
| NO890261D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive tetrahydropyridin-derivater. | |
| ES279057U (es) | Jeringuilla para inyecciones | |
| DK301589D0 (da) | Laegemiddel med thrombolytisk virkning | |
| NO882201L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive pyridinderivater. | |
| IT8722572A0 (it) | Apparecchio medicale per iniezione controllata di medicinali. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEIH | Change in the person of patent owner | ||
| EEFA | Change of the company name | ||
| REN | Ceased due to non-payment of the annual fee |